• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Worldwide Point of Care Diagnostic Test Markets

$2,800.00 – $5,990.00

Clear
SKU: KLI2828762 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Pages: 390
  • Description
  • Table of Contents
  • Latest reports

Description

Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics.

Moreover POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. As more diagnostic manufacturers pursue CLIA waiver status for their POC devices and CE Mark for POC or self use, more decentralized test venues are investing in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care and the world market for POC tests has shown consistent growth, a trend that is expected to continue.
This report, Worldwide Point of Care Testing Markets, includes the following:

 

  • Market Estimates and Forecasts for POC OTC
  • Market Estimates and Forecasts for POC Professional Testing
  • Product Information
  • Products in Development
  • Revenues (2009) of Leading Companies
  • Trends in POC Testing
  • Company Profiles
  • Analyst Conclusions

 

 

The field for rapid test devices is crowded, worldwide, more than 100 companies market rapid tests using the whole gamut of instruments, devices and technologies that reduce test times to minutes or hours in some cases. Growth in POC testing is fueled by the increasing number of diagnosed diabetics, by the globalization of infectious diseases and the associated public health issues, and by the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions.

Market analysis in this report covers world markets for point of care tests, however the reader will find a bias toward the developed areas of the globe — North America, Japan and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers POC products related to global public health and healthcare delivery issues. The following specific POC testing segments are included:

  • Glucose Testing
  • Critical Care
  • Infectious Diseases
  • Urinalysis
  • Cholesterol
  • HbA1c
  • Coagulation
  • Hematology,
  • Chemistry/Immunoassays
  • Infectious Diseases,
  • Fecal Occult Blood
  • Pregnancy,
  • Cardiac Markers
  • Oncology
  • Urinalysis,
  • Drugs of Abuse

All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Data are presented in U.S. dollars and the market size for categories of tests, and for specific analytes is provided where possible with certainty. The dollar value of a market segment is directly proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.

The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author’s industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of POC tests, decentralized healthcare and healthcare economics.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

For Kalorama’s take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information’s Key Point Blog at http://kaloramakeypoint.blogspot.com/

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Scope and Methodology
  • Size and Growth of the Market
  • Market Trends

CHAPTER TWO: INTRODUCTION

  • Miniaturization, digitization and informatics
  • The pros and cons of POC testing
  • Point of View

CHAPTER THREE: ECONOMICS, EMR AND HEALTHCARE REFORM

  • Healthcare Reform
  • POC and Clinical Outcomes Management
  • POC’s Unmet Need

CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS

  • Backgroun
  • The search for non-invasive tools
  • Saliva
  • Breath
  • Optical Techniques
  • Patch Technology
  • Wearable Sensors/Textiles
  • The Wireless Revolution
  • Connectivity Imperative
  • Lab-on-a chip

CHAPTER FIVE: VENUES FOR POC TESTING

  • POC Testing in the Hospital
  • POL and Clinic Testing
  • Retail Outlets
  • Other Professional POC Venues – Workplace Testing and Home Visits
  • Home Monitoring of Individuals with Chronic Diseases
  • Self-Test Sector – OTC Tests

CHAPTER SIX: MARKET ANALYSIS

  • Market Overview
  • Prognosis for POC growth
  • Technological Challenges
  • Market and Forecasts
  • Self Testing/OTC
  • Breakout of Non-Glucose Testing
  • Professional POC Testing
  • POC in world markets
  • Europe
  • Asia
  • Rest of World
  • United States
  • Physician Office Labs
  • United Kingdom
  • HIV/AIDS
  • Market for Rapid Flu Testing
  • The Major Players
  • Licenses and Distribution Agreements
  • Struggling Competitors

CHAPTER SEVEN: POC TEST SEGMENTS

  • Diabetes Testing – Blood Glucose Monitoring (BGM)
  • Blood Glucose Self-Testing
  • Blood Glucose Testing by Professionals
  • Diabetes Testing – Glycated Hemoglobin
  • Cardiovascular Diagnostics
  • Cardiac Markers (AMI enzymes)
  • Cholesterol/Lipid Panels
  • Clinical Chemistry/Critical Care
  • Hemoglobin Testing for Anemia
  • Hematology
  • Coagulation
  • Decentralized Coagulation testing – Professional Use
  • Decentralized Coagulation Testing – OTC
  • Drugs of Abuse/Therapeutic Drug Monitoring
  • Allergy
  • Infectious Diseases
  • OTC Tests for Infectious Diseases
  • Professional POC Tests for Infectious Diseases
  • Pharmacodiagnostics
  • Sepsis
  • Oncology
  • Bladder Cancer
  • Colon Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Women’s Health / Pregnancy/Fertility
  • Emerging Tests and Technologies
  • Commercial Outlook

CHAPTER EIGHT: COMPANY PROFILES MAJOR COMPANIES

  • Abbott Diagnostics
    • Diabetes
    • Critical Care
    • Hematology
  • ARKRAY, Inc.
    • Distribution News
    • Product News
  • Bayer Diabetes Care
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company (BD)
  • bioMerieux Inc.
  • Bio-Rad Laboratories Inc.
  • GE Healthcare
  • Instrumentation Laboratory
  • Inverness Medical Innovations
  • Lifescan Inc.
  • Nova Biomedical
  • Ortho Clinical Diagnostics (OCD)
  • Qiagen N.V.
  • Quidel Corporation
  • Radiometer A/S
  • Roche Diagnostics
    • Diabetes
    • Cardiac Markers
    • Clinical Chemistry
    • Critical Care
  • Siemens Healthcare Diagnostics
    • Cardiac Markers
    • Diabetes Care
    • Blood Gases
    • Urinalysis
  • Sysmex Corporation
  • TOSOH Corporation

CHAPTER NINE: NEW FRONTIER POC COMPANIES

  • 3M Health Care
  • 77 Elektronika Kft.
  • Abaxis, Inc.
  • A/C Diagnostics
  • Accumetrics
  • ACIST Medical Systems, Inc.
  • AgaMetrix, Inc.
  • Alfa Wassermann Diagnostic Technologies, LLC (AWDT)
  • American Bio Medica Corp
  • Audit Diagnostics
  • Axis-Shield plc
  • Biohit Oy
  • BioIQ
  • Biomerica, Inc.
  • Biosite Incorporated
  • B.R.A.H.M.S. AG
  • Calypte Biomedical Corporation
  • Chembio Diagnostic Systems, Inc.
  • Chempaq A/S
  • Cholestech Corporation
  • Concateno plc
  • DexCom, Inc.
  • Diabetech, LP
  • Diazyme Laboratories
  • EKF-diagnostic GmbH
  • ESA Biosciences Inc.
  • Hain Lifescience GmbH
  • HandyLab, Inc.
  • Helena Laboratories USA
  • Hema Diagnostic Systems (HDS)
  • HemoCue AB
  • HemoSense, Inc.
  • Home Diagnostics, Inc.
  • Horiba ABX S.A.
  • Insulet Corporation
  • International Technidyne Corp (ITC)
  • Masimo Corporation
  • Matritech
  • Medical Automation Systems, Inc.
  • MedMira Inc.
  • Medtronic Inc.
  • A. Menarini Diagnostics
  • Meridian Bioscience
  • MP Biomedicals LLC
  • Nanosphere, Inc.
  • OPTI Medical Systems, Inc.
  • OraSure Technologies, Inc.
  • Phadia AB
  • Philips Handheld Immunoassays
  • Polymedco, Inc.
  • QBC Diagnostics, Inc.
  • Response Biomedical Corp.
  • Serotec (AbD Serotec)
  • Smiths Medical MD, Inc. (formerly Deltec, Inc.)
  • Stanbio Laboratory
  • Taidoc Technology Corp.
  • Trinity Biotech plc
  • Via Medical Corporation
  • Vital Diagnostics

CHAPTER TEN: OTHER PLAYERS

  • Acrongenomics Inc.
  • Alfa Scientific Designs, Inc.
  • Amic AB
  • Astron Clinica
  • AspenBio Pharma, Inc.
  • AT First Diagnostic, LLC
  • bioLytical Laboratories Inc.
  • Biomagnetics Diagnostics Corporation
  • Bionime Corporation
  • BodyTel Scientific, Inc.
  • Burnet Institute
  • Celerus Diagnostics
  • Chelsea Technologies Group Ltd
  • Claros Diagnostics
  • CLX Medical, Inc.
  • ContraVac, Inc.
  • Decision Biomarkers Inc.
  • Diabetes Sentry Products Inc.
  • Diaglobal GmbH
  • Diagnostic Devices, Inc.
  • Diagnostics for All (DFA)
  • Diagnostics for the Real World (DRW)
  • Digital Bio Technology/ InCyto
  • Diversa Limited (formerly Ambri Ltd.)
  • DNAFORM
  • DxNA
  • Echo Therapeutics, Inc. (previously Sontra Medical)
  • Enigma Diagnostics Limited
  • Enterix Inc.
  • Entra Health Systems
  • Epocal, Inc.
  • EUMED Biotechnology Co. Ltd.
  • eScreen, Inc.
  • EyeMarker Systems, Inc.
  • Flexsite Diagnostics, Inc.
  • Fora Care
  • GenBio
  • Gene Smart Wellness
  • Gentag Inc.
  • Glucometrics, Inc.
  • Guided Therapeutics, Inc.
  • Hai Kang Life Corporation
  • HealthPia America
  • Heidelberger-Medical-Marketing GmbH (HMM GmbH)
  • Hema Metrics
  • Hoana Medical, Inc.
  • Idaho Technology, Inc.
  • Identa Corporation
  • Identigene
  • Innovative Biosensors, Inc.
  • Integrity Applications Ltd.
  • Intel Corporation
  • LifeAssays AB
  • LifeSign LLC
  • Lifestyle Choices Ltd
  • Luminous Medical, Inc.:
  • M-Biotech
  • Menssana Research, Inc.
  • Micromem Technologies Inc.
  • Micronics Inc.
  • MicroPhage, Inc.
  • Multilyte Limited
  • MycroLab Pty Ltd.
  • Nanomix, Inc.
  • National Jewish Health
  • Network Biosystems
  • Neuroptix Corporation
  • Noninvasive Medical Technologies, Inc.
  • OrSense Ltd.
  • OvumOptics, Inc.
  • Oxonica Diagnostics
  • PlaCor, Inc.
  • PointCare Technologies
  • Probe Scientific Ltd
  • Prometheus Laboratories Inc.
  • Q-linea
  • Quadraspec
  • QualSec, Inc
  • QuantRx Biomedical Corporation
  • Quotient Diagnostics
  • Rapid Pathogen Screening
  • Rennesens GmbH
  • Screening Devices Canada, Inc.
  • Sentinel Bioactive Paper Network
  • Sphere Medical Ltd.
  • SIENCO
  • Smiths Detection
  • Solei Systems, Inc.
  • Solianis Monitoring AG
  • SpheroSense Technologies Inc.
  • STD Test Express
  • Surface Enhanced Micro Optical Fluidic Systems
  • T2 Biosystems, Inc.
  • TwistDx, Ltd.
  • Veralight, Inc.
  • Veredus Laboratories Pte
  • VeriChip Corporation
  • Vivacta Limited

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: Exchange Rate Fluctuations, 2005-200
  • Table 1-2: POC Sales by Test Category (OTC and POC), Worldwide 2008-2011

CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS

  • Table 4-1: Selected Non-Invasive Testing Innovations
  • Table 4-2: Selected disease markers in exhaled breath
  • Table 4-3: Selected POC Wireless Innovations, 2008-2009
  • Table 4-4: RALS connected POC systems, 2009
  • Table 4-5: Selected biochip and biosensor innovations, 2009

CHAPTER FIVE: VENUES FOR POC TESTING

  • Figure 5-1: Venues for POC Testing (Hospital, Physician, Other)
  • Table 5-1: POC Test Sales in the Hospital Sector (Critical Care, Glucose, Cardiac Markers, Infectious Diseases, Coagulation, Hematology, Drugs of Abuse, Cholesterol, Pregnancy, Urinalysis), 2008
  • Table 5-2: POC Test Sales in the POL Sector (Glucose, Cholesterol, HbA1c, Coagulation, Hematology, Chemistry/Immunoassays, Infectious Diseases, Fecal Occult Blood, Pregnancy, Cardiac Markers, Oncology, Urinalysis, Drugs of Abuse), 2008
  • Table 5-3: Selected Small Footprint Chemistry Systems, 2009
  • Table 5-4: Selected Small Footprint Hematology Systems, 2009
  • Table 5-5: Selected New Small Footprint Immunoassay Systems, 2009
  • Table 5-6: POC Test Sales in Other Care Venues (Glucose, Cholesterol, Drugs of Abuse, Fecal Occult Blood, Infectious Diseases, Urinalysis, Coagulation), 2008
  • Table 5-7: Selected self-test innovations, 2008-2009

CHAPTER SIX: MARKET ANALYSIS

  • Table 6-1: OTC/Self Test Sales by Test Category (Glucose, Pregnancy, Coagulation, Fecal Occult Blood, Drugs of Abuse, HbA1c, HIV, Cholesterol, Other) Worldwide 2008 and 2013
  • Figure 6-1: Breakout of Non-Glucose Self-Testing
  • Figure 6-2: Professional POC Testing Market by Test Category
  • Table 6-2: Professional Point of Care Testing Market by Test Category (Glucose, Critical Care, Cardiac Markers, Infectious Diseases, Cholesterol/Lipids, Coagulation, Hematology, HbA1c, Chemistry/Immunoassays, Fecal Occult Blood, Drugs of Abuse, Pregnancy, Urinalysis, Onocology, Other) 2008 and 2013
  • Figure 6-3: Professional POC Testing Market by Test Category
  • Table 6-3: POC Test Sales by Region (US, Europe, Asia, ROW), 2008-2013
  • Table 6-4: POC Test Revenues of Selected IVD Companies, $ million, estimated
  • Table 6-5: Selected Market Expansion Deals in POC testing, 2008-2009

CHAPTER SEVEN: POC TEST SEGMENTS

  • Table 7-1: World Glucose Monitoring Sales, by Company, 2005 – 2008
  • Table 7-2: Selected Glucose Meter Innovations, 2008-2009
  • Table 7-3: Selected Wireless Enabled Blood Glucose Monitors, 2009
  • Table 7-4: Selected Continuous BGM Sales by Company, 2008
  • Table 7-5: Selected Continuous Blood Glucose Systems, 2009
  • Table 7-6: Glucose Meters that use GDH-PQQ technology
  • Table 7-7: Selected POC HbA1c Devices, 2009
  • Table 7-8: Worldwide Sales, POC CVD markers (Cholesterol -Professional, Cholesterol OTC, AMI Enzymes), 2008-2013
  • Table 7-9: Selected POC Hematology Systems, 2009
  • Table 7-10: World POC Coagulation Sales(PT-Professional, PT OTC, ACT), 2008 (million)
  • Table 7-11: Selected CLIA Waived PT Devices
  • Table 7-12: Selected Rapid HIV Tests on the Market
  • Table 7-13: Selected Rapid Infectious Disease Test Innovations
  • Table 7-14: Selected Women’s Health OTC Tests
  • Table 7-15: Selected POC Platform Innovations, 2008/2009

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00
  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    $2,995.00 – $5,990.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
European Vaccine Markets: Germany, UK, France, Spain, Italy, Rest of EuropeSample Preparation and Library Preparation for DNA Sequencers (Results of The...
Scroll to top